Staff Structural and Coronary Interventionalist
Cleveland Clinic
Shaker Heights, Ohio, United States
Rishi joined the Cleveland Clinic as Staff Coronary & Structural Interventionalist in 2018. Rishi is Australian born & trained; undertook post-doctoral training in the IVUS/Angio Core Lab of the Cleveland Clinic, serving as its Medical director for 2 years. Rishi pursued further coronary/structural interventional training at the Quebec Heart & Lung Institute, & the Rennes University Hospital, France. His clinical & academic interests include structural heart interventions, complex coronary interventions, device innovation, prevention, plaque imaging and pharmacological studies of novel anti-atherosclerotic compounds. Rishi has published over 350 original manuscripts in each of the leading medical & cardiology journals, and was the 2011 ACC Young Investigator & 2016 TCT Linnemeier Finalist.
Saturday, February 25, 2023
2:00 PM – 3:30 PM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing); Bioventrix: Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Centerline BioMedical: Advisor (Ongoing), Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); VahatiCor: Advisor (Ongoing), Board Member (Ongoing), Consultant (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Zoll- Therox: Advisor (Ongoing), Consultant (Ongoing)
Saturday, February 25, 2023
3:30 PM – 4:30 PM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing); Bioventrix: Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Centerline BioMedical: Advisor (Ongoing), Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); VahatiCor: Advisor (Ongoing), Board Member (Ongoing), Consultant (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Zoll- Therox: Advisor (Ongoing), Consultant (Ongoing)
Saturday, February 25, 2023
6:00 PM – 7:50 PM ET
Disclosure(s): Abbott: Consultant/Advisory Board (Ongoing); Bioventrix: Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Centerline BioMedical: Advisor (Ongoing), Consultant (Ongoing), Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); GE Healthcare: Consultant/Advisory Board (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); VahatiCor: Advisor (Ongoing), Board Member (Ongoing), Consultant (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Zoll- Therox: Advisor (Ongoing), Consultant (Ongoing)